Pathological Examination Market set to strong growth with a CAGR 0f 9.9%- Market Size, Share, Industry, Forecast | key Players:- 3DHISTECH Ltd., NeoGenomics Laboratories, Inc., F. Hoffmann-La Roche Ltd

Global Pathological Examination Market is expected to grow at a CAGR 0f 9.9% during the forecast period (2024-2031).

The market is growing due to rising cancer and chronic disease incidence, increasing demand for early and accurate diagnosis, advances in digital pathology and AI, expanding healthcare infrastructure, and higher adoption of biopsy-based and personalized diagnostic procedures worldwide.

Download your exclusive free sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/pathological-examination-market?pratik

United States: Key Industry Developments:-
✅ September 2025: Roche Diagnostics launched an AI-assisted digital pathology platform for automated tissue analysis and diagnostic accuracy, integrating advanced imaging and machine learning for faster results in hospitals and labs.​

✅ August 2025: Leica Biosystems acquired a U.S.-based pathology imaging startup, expanding digital slide scanning and automated tissue analysis to enhance high-throughput diagnostic workflows with AI-driven insights.​

✅ July 2025: Thermo Fisher Scientific invested $50 million in pathology lab automation and digital imaging facilities, focusing on next-generation staining, imaging, and AI analytics for reliable clinical examinations.​

Japan: Key Industry Developments:-
✅ July 2025: Hitachi High-Tech Corporation acquired a domestic pathology software startup specializing in AI-driven tissue analysis, bolstering digital pathology and workflow automation for hospital diagnostics.​

✅ June 2025: NEC Corporation launched a cloud-based AI pathology system for automated tissue evaluation, remote diagnostics, and predictive analysis, improving efficiency in clinical and research applications.

Recent M&A (2025):-
March 2025: Quest Diagnostics acquired a regional anatomic pathology laboratory network in the U.S. Midwest to expand histopathology, cytopathology, and oncology testing capacity, strengthening its hospital and physician outreach services in high-volume cancer diagnostics (Q1 2025).

February 2025: Sonic Healthcare completed the acquisition of a specialty pathology services provider in Western Europe, enhancing advanced tissue diagnostics, molecular pathology, and digital pathology workflows across hospital-based laboratories (Q1 2025).

January 2025: Eurofins Scientific acquired a private clinical pathology laboratory group focused on gastrointestinal and dermatopathology, broadening its clinical diagnostics portfolio and increasing penetration in physician-referred pathological examination services (Q1 2025).

Growth Forecast Projection:-
The Pathological Examination Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:-
Both primary and secondary data sources have been used in the Pathological Examination Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

"Secure your 30% year-end discount - get this report before the offer expires.":https://www.datamintelligence.com/buy-now-page?report=pathological-examination-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

Consumer Preferences
Users favor comprehensive panels covering organs like digestive systems and gynecology, with "other applications" growing quickest. High awareness post-pandemic boosts routine screenings, but cost sensitivity drives demand for affordable, high-precision options in emerging regions.

Companies and Competitive Landscape
Major key players in the pathological examination market are 3DHISTECH Ltd., NeoGenomics Laboratories, Inc., F. Hoffmann-La Roche Ltd, Bio SB, Agilent Technologies, Inc., Quest Diagnostics Incorporated, Sonic Healthcare, Diapath S.p.A., BioGenex, Leica Biosystems

3DHISTECH Ltd.:
3DHISTECH, founded in 1996, is the first European manufacturer of digital pathology devices and one of the global market leaders, with more than 1500 systems sold. It is dedicated to providing clinical pathologists, researchers and universities with digital pathology solutions to facilitate quick and accurate diagnostics, supporting medical discoveries and fostering education. The company is developing and manufacturing a wide range of PANNORAMIC whole slide scanners, Track & Sign and CaseManager laboratory and pathology management, CaseViewer digital microscopy and QuantCenter image analysis software solutions. Other products include tissue microarray machinery.

Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Market segmentation-
By Test (Digital Pathology, Traditional Pathology),
By Service (Anatomic Pathology, Surgical Pathology, Molecular Pathology, Cytopathology, Clinical Pathology, Others),
By Application (Genetic Abnormalities, Neoplasm, Infections, Cardiovascular Diseases, Others),
By End user (Hospitals, Research Institutes, Diagnostic Centers, Others)
Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/pathological-examination-market?pratik

FAQs -
1. What is the projected CAGR value of the Pathological Examination Market?
Pathological Examination Market is expected to grow at a CAGR of 9.9% during the forecast period 2024-2031.

2. Which region controlled the global market during 2024-2031?
The North America region controls the Pathological Examination Market during 2024-2031.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook

This release was published on openPR.